[1]
|
Physicians Desk Reference (2013) Rayos. A Concise Monograph. http://fda.net/
|
[2]
|
Buttgereit, F., Doering, G., Schaeffler, A., Witte, S., Sierakowski, S., Gromnica-Ihle, E., et al., (2008) Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (Capra-1): A double-blind, randomized controlled trial. The Lancet, 371, 205-214.
doi:10.1016/S0140-6736(08)60132-4
|
[3]
|
Straub, R.H. and Cutulo, M. (2007) Circadian rhythms in rheumatoid arthritis. Arthritis & Rheumatism, 56, 399-408. doi:10.1002/art.22368
|
[4]
|
Arvidson, N.G., Gudbjornsson, B., Larsson, A. and Hallgren, R. (1997) The timing of glucocorticoid administration in rheumatoid arthritis. Annals of the Rheumatic Diseases, 56, 27-31. doi:10.1136/ard.56.1.27
|
[5]
|
Hench, P.S., Kendall, E.C., Slocumb, C.H. and Polley, H.F. (1949) The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proceedings of the Staff Meetings of the Mayo Clinic, 24, 181-197.
|
[6]
|
Ward, L.M., Slocumb, C.H., Polley, H.F., Lowman, E.W. and Hench, P.S. (1951) Clinical effects of cortisone administered orally to patients with rheumatoid arthritis. Proceedings of the Staff Meetings of the Mayo Clinic, 26, 361-370.
|
[7]
|
Ward, L.M., Polley, H.F., Power, M.H., Mason, H.L., Slocumb, C.H. and Hench, P.S. (1958) Prednisone in rheumatoid arthritis: Metabolic and clinical effects. Annals of the Rheumatic Diseases, 17, 145-159.
doi:10.1136/ard.17.2.145
|
[8]
|
Report by the Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of Cortisone, ACTH, and other Therapeutic Measures in Chronic Rheumatic Diseases (1959) A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases, 18, 173-188. doi:10.1136/ard.18.3.173
|
[9]
|
Harter, J.G., Reddy, W.J. and Thorn, G.W. (1963) Studies on an intermittent corticosteroid dosage regimen. The New England Journal of Medicine, 269, 591-596.
doi:10.1056/NEJM196309192691201
|
[10]
|
Black, R.L. (1966) The use of synthetic corticosteroids in rheumatoid arthritis. In: Hollander, J.L., Ed., Arthritis and Allied Conditions, 7th Edition, Lea and Febiger, Philadelphia, 364-380.
|
[11]
|
Hess, E.V. and Goldman, J.A. (1972) Corticosteroids and corticotropin in the therapy of rheumatoid arthritis. In: Hollander, J.L. and McCarty, D.J., Eds., Arthritis and Allied Conditions, 8th Edition, Lea and Febiger, Philadelphia, 495-516.
|
[12]
|
Lightfoot Jr., R.W. (1979) Treatment of rheumatoid arthritis. In: McCarty, D.J., Ed., Arthritis and Allied Conditions, 9th Edition, Lea and Febiger, Philadelphia, 513-518.
|
[13]
|
Ruddy (1985) The management of rheumatoid arthritis. In: Kelley, W.N., Harris Jr., E.D., Ruddy, S. and Sledge, C.B., Eds., Textbook of Rheumatology, 2nd Edition, W.B. Saunders Company, Philadelphia, 979-992.
|
[14]
|
Harris Jr., E.D. (1993) The management of rheumatoid arthritis. In: Kelley, W.N., Harris Jr., E.D., Ruddy, S. and Sledge, C.B., Eds., Textbook of Rheumatology, 4th Edition, W.B. Saunders Company, Philadelphia, 912-923.
|
[15]
|
Kirwan, J.R. (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis: the arthritis and rheumatism council low-dose glucocorticoid study group. The New England Journal of Medicine, 333, 142-146.
doi:10.1056/NEJM199507203330302
|
[16]
|
van Everdingen, A.A., Jacobs, J.W.G., Siewertsz van Reesema, D.R. and Bijlsma, W.J. (2002) Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, diseasemodifying properties, and side effects. Annals of Internal Medicine, 136, 1-12.
doi:10.7326/0003-4819-136-1-200201010-00006
|
[17]
|
Svensson, B., Boonen, A., Albertsson, K., van der Heijde, D., Keller, C. and Hafstrom, I. (2005) Low-dose prednisolone in addition to the initial diesease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate. Arthritis & Rheumatism, 52, 3360-3370.
doi:10.1002/art.21298
|
[18]
|
Wassenberg, S., Rau, R., Steinfeld, P. and Zeidler, H. (2005) Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years. Arthritis & Rheumatism, 52, 3371-3380.
doi:10.1002/art.21421
|
[19]
|
Bakker, M., Jacobs, J.W.G., Weising, P.M.J., Verstappen, SMM, Tekstra, J., Ton, E., et al. (2012) Low-dose prednisone inclusion in methotrexate-based tight control strategy for early rheumatoid arthritis. Annals of Internal Medicine, 156, 329-339.
doi:10.7326/0003-4819-156-5-201203060-00004
|
[20]
|
Da Silva, J.A.P., Jacobs, J.W.G., Kirwan, J.R., Boers, M., Saag, K.G., Ines, L.B.S., et al. (2006) Safety of low dose glucocorticoid treatment in rheumatoid arthritis: Published evidence and prospective trial data. Annals of the Rheumatic Diseases, 65, 285-293.
doi:10.1136/ard.2005.038638
|
[21]
|
Buttgereit, F., Straub, R.H., Wehling, M. and Burmester, G.R. (2004) Glucocorticoids in the treatment of rheumatic diseases. Arthritis & Rheumatism, 50, 3408-3417.
doi:10.1002/art.20583
|
[22]
|
Cidlowski, J.A. (2005) Antiinflammatory action of glucocorticoids—New mechanisms for old drugs. The New England Journal of Medicine, 353, 1711-1723.
doi:10.1056/NEJMra050541
|
[23]
|
Chrousos, G.P. (2009) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. The New England Journal of Medicine, 332, 1351-1362.
|
[24]
|
Straub, R.H., Paimela, L., Peltomaa, R., Scholmerich, J. and Leirisalo-Repo, M. (2002) Inadequate low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis & Rheumatism, 46, 654-662. doi:10.1002/art.10177
|
[25]
|
Buttgereit, F., Hehta, D., Kirwan, J., Szechinski, J., Boers, M., Alten, R., et al. (2013) Low-dose prednisone chronotherapy for rheumatoid arthritis: A randomized clinical trial (Capra-2). Annals of the Rheumatic Diseases, 72, 204-210. doi:10.1136/annrheumdis-2011-201067
|